Compare
Fifth Era Acquisition Corp I vs Sizzle Acquisition Corp. II vs Drugs Made In America Acquisition Corp. vs Cal Redwood Acquisition Corp.
| Latest fiscal year | Fifth Era Acquisition Corp I FERA | Sizzle Acquisition Corp. II SZZL | Drugs Made In America Acquisition Corp. DMAA | Cal Redwood Acquisition Corp. CRAQ |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | n/a | n/a | n/a |
| Revenue growth (YoY) | n/a | n/a | n/a | n/a |
| Gross margin | n/a | n/a | n/a | n/a |
| Operating margin | n/a | n/a | n/a | n/a |
| Net margin | n/a | n/a | n/a | n/a |
| Net income | $4.13M | $6.47M | $5.94M | $5.05M |
| EPS (Diluted) | n/a | n/a | n/a | n/a |
| Operating cash flow | -$890.6K | -$600.8K | -$539.2K | -$446.5K |
| Free cash flow | n/a | n/a | n/a | n/a |
| Cash & equivalents | $543.3K | n/a | n/a | $1.10M |
| Total assets | $238.58M | $237.96M | $239.92M | $236.87M |
| Total liabilities | $14.06M | $11.09M | $7.28M | $9.38M |
| Shareholders' equity | -$13.33M | -$10.13M | -$7.26M | -$8.14M |
| Return on year-end equity | n/a | n/a | n/a | n/a |
| Shares outstanding | n/a | n/a | 10.72M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Fifth Era Acquisition Corp I | Sizzle Acquisition Corp. II | Drugs Made In America Acquisition Corp. | Cal Redwood Acquisition Corp. |
|---|---|---|---|---|
| Latest | n/a | n/a | n/a | n/a |
| 1 year earlier | n/a | n/a | n/a | n/a |
| 2 years earlier | n/a | n/a | n/a | n/a |
| 3 years earlier | n/a | n/a | n/a | n/a |
| 4 years earlier | n/a | n/a | n/a | n/a |